Published in Anal Chem on June 15, 2010
A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol (2010) 2.30
High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics (2010) 1.63
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res (2012) 1.46
High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev (2013) 1.23
Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis (2012) 1.19
Developments in the identification of glycan biomarkers for the detection of cancer. Mol Cell Proteomics (2013) 1.12
Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Mol Cell Proteomics (2013) 1.09
Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum. Electrophoresis (2012) 1.06
Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses. Anal Bioanal Chem (2013) 1.05
The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery. Proteomics (2012) 1.02
Defining putative glycan cancer biomarkers by MS. Bioanalysis (2012) 0.99
Protein biomarkers for the early detection of breast cancer. Int J Proteomics (2011) 0.98
Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A (2013) 0.95
Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins. Mol Cell Proteomics (2012) 0.94
Glycomic profiling of tissue sections by LC-MS. Anal Chem (2013) 0.92
Smoking and lung cancer-induced changes in N-glycosylation of blood serum proteins. Glycobiology (2012) 0.92
Glycoproteomics-based identification of cancer biomarkers. Int J Proteomics (2011) 0.92
Glycomic analysis by glycoprotein immobilization for glycan extraction and liquid chromatography on microfluidic chip. Anal Chem (2013) 0.90
Analytical glycobiology at high sensitivity: current approaches and directions. Glycoconj J (2012) 0.90
GlycoPep Detector: a tool for assigning mass spectrometry data of N-linked glycopeptides on the basis of their electron transfer dissociation spectra. Anal Chem (2013) 0.89
Improving N-glycan coverage using HPLC-MS with electrospray ionization at subambient pressure. Anal Chem (2012) 0.89
The sweet and sour of serological glycoprotein tumor biomarker quantification. BMC Med (2013) 0.88
Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomics. Chem Rev (2015) 0.88
2D-LC analysis of BRP 3 erythropoietin N-glycosylation using anion exchange fractionation and hydrophilic interaction UPLC reveals long poly-N-acetyl lactosamine extensions. Anal Chem (2011) 0.85
Recent trends in analytical and structural glycobiology. Curr Opin Chem Biol (2013) 0.85
Systematic comparison of reverse phase and hydrophilic interaction liquid chromatography platforms for the analysis of N-linked glycans. Anal Chem (2012) 0.85
Microfluidic chip-based technologies: emerging platforms for cancer diagnosis. BMC Biotechnol (2013) 0.84
Exploiting bacterial glycosylation machineries for the synthesis of a Lewis antigen-containing glycoprotein. J Biol Chem (2011) 0.84
Glycomic Alterations in the Highly-abundant and Lesser-abundant Blood Serum Protein Fractions for Patients Diagnosed with Hepatocellular Carcinoma. Int J Mass Spectrom (2011) 0.83
Hemelipoglycoprotein from the ornate sheep tick, Dermacentor marginatus: structural and functional characterization. Parasit Vectors (2011) 0.82
Protein and site specificity of fucosylation in liver-secreted glycoproteins. J Proteome Res (2014) 0.81
Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis. ScientificWorldJournal (2013) 0.80
Structural glycomic analyses at high sensitivity: a decade of progress. Annu Rev Anal Chem (Palo Alto Calif) (2013) 0.80
Multiple precursor ion scanning of gangliosides and sulfatides with a reversed-phase microfluidic chip and quadrupole time-of-flight mass spectrometry. Anal Chem (2012) 0.79
Examination of glycan profiles from IgG-depleted human immunoglobulins facilitated by microscale affinity chromatography. Anal Chem (2012) 0.79
Novel data analysis tool for semiquantitative LC-MS-MS2 profiling of N-glycans. Glycoconj J (2012) 0.79
Glycans and glycoproteins as specific biomarkers for cancer. Anal Bioanal Chem (2016) 0.79
Complementary Glycomic Analyses of Sera Derived from Colorectal Cancer Patients by MALDI-TOF-MS and Microchip Electrophoresis. Anal Chem (2016) 0.78
Glycomic profiling of glycoproteins. Glycoconj J (2013) 0.78
Resolving Isomeric Glycopeptide Glycoforms with Hydrophilic Interaction Chromatography (HILIC). J Biomol Tech (2016) 0.78
Recent advances in the MS analysis of glycoproteins: Capillary and microfluidic workflows. Electrophoresis (2010) 0.77
Recent Advances in the Analysis of Complex Glycoproteins. Anal Chem (2016) 0.77
Sub 2-μm macroporous silica particles derivatized for enhanced lectin affinity enrichment of glycoproteins. Anal Chem (2013) 0.77
Integrated Microfluidic Lectin Barcode Platform for High-Performance Focused Glycomic Profiling. Sci Rep (2016) 0.77
Structural Characterization of Serum N-Glycans by Methylamidation, Fluorescent Labeling, and Analysis by Microchip Electrophoresis. Anal Chem (2016) 0.77
Purification of derivatized oligosaccharides by solid phase extraction for glycomic analysis. PLoS One (2014) 0.76
Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues. Curr Drug Metab (2012) 0.76
LC-MS/MS of permethylated N-glycans derived from model and human blood serum glycoproteins. Electrophoresis (2016) 0.76
Polysialylated N-glycans identified in human serum through combined developments in sample preparation, separations, and electrospray ionization-mass spectrometry. Anal Chem (2014) 0.75
Reversed-phase separation methods for glycan analysis. Anal Bioanal Chem (2016) 0.75
Serum glycoprotein-derived N- and O-linked glycans as cancer biomarkers. Am J Cancer Res (2016) 0.75
LC-MS/MS isomeric profiling of permethylated N-glycans derived from serum haptoglobin of hepatocellular carcinoma (HCC) and cirrhotic patients. Electrophoresis (2017) 0.75
A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE. J Biochem (1964) 14.38
Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer. J Proteome Res (2006) 2.99
Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr (1990) 2.49
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology (2007) 2.45
Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res (2007) 2.30
Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom (2005) 2.27
Analysis of immunoglobulin glycosylation by LC-ESI-MS of glycopeptides and oligosaccharides. Proteomics (2008) 2.26
Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal Biochem (1997) 2.12
A serum glycomics approach to breast cancer biomarkers. Mol Cell Proteomics (2006) 2.03
Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem (2008) 1.96
Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J Proteome Res (2006) 1.93
Elimination of oxidative degradation during the per-O-methylation of carbohydrates. J Am Chem Soc (2003) 1.90
Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom Rev (2000) 1.87
Electrospray interface for liquid chromatographs and mass spectrometers. Anal Chem (1985) 1.84
High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.74
Profiling of human serum glycans associated with liver cancer and cirrhosis by IMS-MS. J Proteome Res (2008) 1.66
A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology (2008) 1.55
Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans. Anal Chem (2007) 1.54
Nanoliquid chromatography-mass spectrometry of oligosaccharides employing graphitized carbon chromatography on microchip with a high-accuracy mass analyzer. Electrophoresis (2005) 1.53
N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis. J Proteome Res (2007) 1.51
Glycomic approach for potential biomarkers on prostate cancer: profiling of N-linked glycans in human sera and pRNS cell lines. Dis Markers (2008) 1.41
Molecular bonding and interactions at aqueous surfaces as probed by vibrational sum frequency spectroscopy. Chem Rev (2002) 1.39
A glycomics platform for the analysis of permethylated oligosaccharide alditols. J Am Soc Mass Spectrom (2007) 1.38
Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem (2001) 1.38
ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics. Rapid Commun Mass Spectrom (2008) 1.24
Influence of electrosorption, solvent, temperature, and ion polarity on the performance of LC-ESI-MS using graphitic carbon for acidic oligosaccharides. Anal Chem (2008) 1.19
Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients. Anal Chem (2009) 1.17
Negative ion graphitised carbon nano-liquid chromatography/mass spectrometry increases sensitivity for glycoprotein oligosaccharide analysis. Rapid Commun Mass Spectrom (2004) 1.16
Hydrophilic interaction chromatography-based high-throughput sample preparation method for N-glycan analysis from total human plasma glycoproteins. Anal Chem (2008) 1.13
Normal-phase nanoscale liquid chromatography-mass spectrometry of underivatized oligosaccharides at low-femtomole sensitivity. Anal Chem (2004) 1.12
Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res (2008) 1.12
The fundamental aspects and applications of Agilent HPLC-Chip. J Sep Sci (2007) 1.11
Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. Glycobiology (1998) 1.07
Use of a porous graphitised carbon column for the high-performance liquid chromatography of oligosaccharides, alditols and glycopeptides with subsequent mass spectrometry analysis. J Chromatogr (1993) 1.06
Reversed-phase liquid chromatographic separation of complex samples by optimizing temperature and gradient time I. Peak capacity limitations. J Chromatogr A (1999) 1.04
Oligosaccharide relative quantitation using isotope tagging and normal-phase liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.04
Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem (1989) 1.03
Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res (2000) 1.02
Matrix-assisted laser desorption/ionization mass spectrometry compatible beta-elimination of O-linked oligosaccharides. Rapid Commun Mass Spectrom (2002) 0.97
High-performance liquid chromatography of oligosaccharide alditols and glycopeptides on a graphitized carbon column. J Chromatogr (1992) 0.95
Changes of serum glycans during sepsis and acute pancreatitis. Glycobiology (2007) 0.95
Hydrophilic-interaction chromatography of complex carbohydrates. J Chromatogr A (1994) 0.92
Liquid chromatography ion trap mass spectrometric analysis of oligosaccharides using permethylated derivatives. Rapid Commun Mass Spectrom (2001) 0.92
N-glycomic changes in human breast carcinoma MCF-7 and T-lymphoblastoid cells after treatment with herceptin and herceptin/Lipoplex. J Proteome Res (2010) 0.91
On-line high-performance liquid chromatography/mass spectrometric characterization of native oligosaccharides from glycoproteins. Rapid Commun Mass Spectrom (2002) 0.90
Stationary phases for hydrophilic interaction chromatography, their characterization and implementation into multidimensional chromatography concepts. J Sep Sci (2008) 0.89
Highly efficient analysis of underivatized carbohydrates using monolithic-silica-based capillary hydrophilic interaction (HILIC) HPLC. Anal Bioanal Chem (2008) 0.88
Analysis of total N-glycans in cell membrane fractions of cancer cells using a combination of serotonin affinity chromatography and normal phase chromatography. J Proteome Res (2006) 0.88
Screening of underivatized oligosaccharides extracted from the stems of Triticum aestivum using porous graphitized carbon liquid chromatography-mass spectrometry. Anal Chem (2007) 0.85
Differentiation of isomeric N-glycan structures by normal-phase liquid chromatography-MALDI-TOF/TOF tandem mass spectrometry. Anal Chem (2006) 0.84
Structural analysis of permethylated oligosaccharides using electrospray ionization quadrupole time-of-flight tandem mass spectrometry and deutero-reduction. Rapid Commun Mass Spectrom (2004) 0.84
Glycomic/glycoproteomic analysis by liquid chromatography/mass spectrometry: analysis of glycan structural alteration in cells. Proteomics (2005) 0.82
Adaptation of a thermospray liquid chromatography/mass spectrometry interface for use with alkaline anion exchange liquid chromatography of carbohydrates. Anal Chem (1990) 0.81
The use of high-performance anion-exchange chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to monitor and identify oligosaccharide degradation. Anal Biochem (1996) 0.80
Characterisation and proposed origin of mass spectrometric ions observed 30 Th above the ionised molecules of per-O-methylated carbohydrates. Rapid Commun Mass Spectrom (2005) 0.78
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71
A computational approach toward label-free protein quantification using predicted peptide detectability. Bioinformatics (2006) 2.48
Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res (2007) 2.30
Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom (2005) 2.27
Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem (2008) 1.96
Structural investigations of glycoconjugates at high sensitivity. Chem Rev (2002) 1.79
High-throughput solid-phase permethylation of glycans prior to mass spectrometry. Rapid Commun Mass Spectrom (2008) 1.74
Individual and gender fingerprints in human body odour. J R Soc Interface (2007) 1.65
Characterization of glycopeptides by combining collision-induced dissociation and electron-transfer dissociation mass spectrometry data. Rapid Commun Mass Spectrom (2009) 1.60
Development of high-sensitivity ion trap ion mobility spectrometry time-of-flight techniques: a high-throughput nano-LC-IMS-TOF separation of peptides arising from a Drosophila protein extract. Anal Chem (2003) 1.54
Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res (2009) 1.52
N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res (2012) 1.46
Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics (2009) 1.45
Pheromone binding by polymorphic mouse major urinary proteins. Protein Sci (2002) 1.39
Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. PLoS One (2015) 1.38
Resolving and assigning N-linked glycan structural isomers from ovalbumin by IMS-MS. J Am Soc Mass Spectrom (2008) 1.37
Structural characterization of oligosaccharides using MALDI-TOF/TOF tandem mass spectrometry. Anal Chem (2003) 1.27
Comparative glycomic mapping through quantitative permethylation and stable-isotope labeling. Anal Chem (2007) 1.26
Electrophoretic analysis of N-glycans on microfluidic devices. Anal Chem (2007) 1.26
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res (2009) 1.25
Glycomic profiling of invasive and non-invasive breast cancer cells. Glycoconj J (2008) 1.24
ProteinQuant Suite: a bundle of automated software tools for label-free quantitative proteomics. Rapid Commun Mass Spectrom (2008) 1.24
High-sensitivity analytical approaches for the structural characterization of glycoproteins. Chem Rev (2013) 1.23
Solid-phase permethylation for glycomic analysis. Methods Mol Biol (2009) 1.21
A proteomic survey of rat cerebral cortical synaptosomes. Proteomics (2005) 1.16
Characterizing protein glycosylation sites through higher-energy C-trap dissociation. Rapid Commun Mass Spectrom (2010) 1.16
Advancement in protein inference from shotgun proteomics using peptide detectability. Pac Symp Biocomput (2007) 1.15
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci U S A (2006) 1.13
Glycomic analysis of sialic acid linkages in glycans derived from blood serum glycoproteins. J Proteome Res (2010) 1.13
The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS. Proteomics (2006) 1.12
Application of dissimilarity indices, principal coordinates analysis, and rank tests to peak tables in metabolomics of the gas chromatography/mass spectrometry of human sweat. Anal Chem (2007) 1.12
Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. J Proteome Res (2008) 1.12
Automated interpretation of MS/MS spectra of oligosaccharides. Bioinformatics (2005) 1.12
Combining lectin microcolumns with high-resolution separation techniques for enrichment of glycoproteins and glycopeptides. Anal Chem (2005) 1.11
Improving confidence in detection and characterization of protein N-glycosylation sites and microheterogeneity. Rapid Commun Mass Spectrom (2011) 1.10
Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. J Proteome Res (2010) 1.10
Efficacy of glycoprotein enrichment by microscale lectin affinity chromatography. J Sep Sci (2008) 1.08
LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma. J Proteome Res (2014) 1.08
A monolithic PNGase F enzyme microreactor enabling glycan mass mapping of glycoproteins by mass spectrometry. Rapid Commun Mass Spectrom (2005) 1.06
Miniaturized separation techniques in glycomic investigations. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.06
Thermodynamic consequences of disrupting a water-mediated hydrogen bond network in a protein:pheromone complex. Protein Sci (2005) 1.06
Comparing MALDI-MS, RP-LC-MALDI-MS and RP-LC-ESI-MS glycomic profiles of permethylated N-glycans derived from model glycoproteins and human blood serum. Electrophoresis (2012) 1.06
Songbird chemosignals: volatile compounds in preen gland secretions vary among individuals, sexes, and populations. Behav Ecol (2010) 1.05
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics (2013) 1.03
Multimethodological approach to identification of glycoproteins from the proteome of Francisella tularensis, an intracellular microorganism. J Proteome Res (2010) 1.03
Seasonal variation in volatile compound profiles of preen gland secretions of the dark-eyed junco (Junco hyemalis). J Chem Ecol (2007) 1.02
New hyphenated methodologies in high-sensitivity glycoprotein analysis. J Sep Sci (2005) 1.02
High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.02
Computational framework for identification of intact glycopeptides in complex samples. Anal Chem (2013) 1.01
Thermodynamic analysis of binding between mouse major urinary protein-I and the pheromone 2-sec-butyl-4,5-dihydrothiazole. Biochemistry (2003) 1.01
Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification. Electrophoresis (2011) 0.99
Chemotaxis assays of mouse sperm on microfluidic devices. Anal Chem (2006) 0.98
Analysis of site-specific glycosylation of renal and hepatic γ-glutamyl transpeptidase from normal human tissue. J Biol Chem (2010) 0.98
Identification of isomeric N-glycan structures by mass spectrometry with 157 nm laser-induced photofragmentation. J Am Soc Mass Spectrom (2008) 0.97
Structural analysis of sulfated glycans by sequential double-permethylation using methyl iodide and deuteromethyl iodide. J Am Soc Mass Spectrom (2009) 0.97
Matrix-assisted laser desorption/ionization mass spectrometry compatible beta-elimination of O-linked oligosaccharides. Rapid Commun Mass Spectrom (2002) 0.97
Enzymatic/chemical release of O-glycans allowing MS analysis at high sensitivity. Anal Chem (2009) 0.97
Assigning N-glycosylation sites of glycoproteins using LC/MSMS in conjunction with endo-M/exoglycosidase mixture. J Proteome Res (2010) 0.97
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. Mol Cell Proteomics (2010) 0.97
Analytical characterization of a facile porous polymer monolithic trypsin microreactor enabling peptide mass mapping using mass spectrometry. Rapid Commun Mass Spectrom (2004) 0.96
Glycomic analysis by capillary electrophoresis-mass spectrometry. Mass Spectrom Rev (2009) 0.96
Semiautomated high-sensitivity profiling of human blood serum glycoproteins through lectin preconcentration and multidimensional chromatography/tandem mass spectrometry. J Proteome Res (2006) 0.96
Differentiating structural isomers of sialylated glycans by matrix-assisted laser desorption/ionization time-of-flight/time-of-flight tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 0.96
Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis. Mol Cell Proteomics (2005) 0.95
Temperature-dependent spectral density analysis applied to monitoring backbone dynamics of major urinary protein-I complexed with the pheromone 2- sec-butyl-4,5-dihydrothiazole. J Biomol NMR (2004) 0.95
Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins. Mol Cell Proteomics (2012) 0.94
Microdeposition device interfacing capillary electrochromatography and microcolumn liquid chromatography with matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem (2004) 0.93
Laser-induced photofragmentation of neutral and acidic glycans inside an ion-trap mass spectrometer. Rapid Commun Mass Spectrom (2007) 0.92